Increased seroreactivity to HERV-K10 peptides in patients with HTLV myelopathy

BACKGROUND: Previously, we had shown that persons infected with human T-cell lymphoma leukemia virus 1 or 2 (HTLV-1 or 2) had an increased prevalence of antibodies to a peptide in the Pol protein of the retrovirus HERV-K10, homologous to a peptide in HTLV gp21 envelope protein. The prevalence rate w...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Perzova, Raisa, Graziano, Elliot, Sanghi, Swathi, Welch, Caitlin, Benz, Patricia, Abbott, Lynn, Lalone, Danielle, Glaser, Jordan, Loughran, Thomas, Sheremata, William, Poiesz, Bernard J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3878045/
https://ncbi.nlm.nih.gov/pubmed/24365054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-10-360
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki